Literature DB >> 24598561

Preservation of kidneys by machine perfusion influences gene expression and may limit ischemia/reperfusion injury.

Michal Wszola1, Artur Kwiatkowski1, Piotr Domagala1, Agnieszka Wirkowska1, Monika Bieniasz1, Piotr Diuwe1, Kieszek Rafał1, Magdalena Durlik1, Andrzej Chmura1.   

Abstract

CONTEXT: Machine perfusion improves graft survival. Histopathologic analysis reveals a lower incidence of chronic rejection and interstitial fibrosis in kidneys preserved with machine perfusion. Ischemic/reperfusion injury may help to explain these findings.
OBJECTIVE: To assess the activation of genes correlated with ischemic/reperfusion injury in kidneys preserved under different conditions before transplant. DESIGN/PATIENTS: Between 2005 and 2006, 69 kidney biopsy specimens were collected and patients were followed up for 5 years after that.Intervention-Before transplant, kidneys were preserved with machine perfusion or cold storage. Donors from the machine perfusion and cold storage groups did not differ with regard to age, sex, or hemodynamic status. Recipients were divided into 5 groups: expanded criteria donor-machine perfusion (n = 16), standard criteria donor-machine perfusion (n = 10), expanded criteria donor-cold storage (n = 9), and standard criteria donor-cold storage (n = 27); 7 kidneys were retrieved from living related donors. MAIN OUTCOME MEASURES: Biopsies were done 30 minutes after reperfusion. Interleukin-1β, vascular endothelial growth factor, heme oxygenase-1, and hypoxia-inducible factor-1 gene expression levels were analyzed.
RESULTS: Mean expression levels of hypoxia-inducible factor-1α were significantly higher in the cold storage groups, and lower in the machine perfusion and living-related donor groups. Five-year graft survival was significantly (P< .05) lower in the expanded criteria donor-cold storage group (66%) than in the standard criteria donor-machine perfusion group (90%). Machine perfusion influences gene expression related to hypoxia during reperfusion and may improve the long-term results of kidney transplant.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24598561     DOI: 10.7182/pit2014384

Source DB:  PubMed          Journal:  Prog Transplant        ISSN: 1526-9248            Impact factor:   1.187


  9 in total

1.  Marked protection against acute renal and hepatic injury after nitrited myoglobin + tin protoporphyrin administration.

Authors:  Richard A Zager
Journal:  Transl Res       Date:  2015-06-10       Impact factor: 7.012

2.  Immunosuppressive nano-therapeutic micelles downregulate endothelial cell inflammation and immunogenicity.

Authors:  Satish N Nadig; Suraj K Dixit; Natalie Levey; Scott Esckilsen; Kayla Miller; William Dennis; Carl Atkinson; Ann-Marie Broome
Journal:  RSC Adv       Date:  2015-04-24       Impact factor: 3.361

3.  Machine perfusion and long-term kidney transplant recipient outcomes across allograft risk strata.

Authors:  Shaifali Sandal; Xun Luo; Allan B Massie; Steven Paraskevas; Marcelo Cantarovich; Dorry L Segev
Journal:  Nephrol Dial Transplant       Date:  2018-07-01       Impact factor: 5.992

Review 4.  Maximizing kidneys for transplantation using machine perfusion: from the past to the future: A comprehensive systematic review and meta-analysis.

Authors:  Ahmer M Hameed; Henry C Pleass; Germaine Wong; Wayne J Hawthorne
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

5.  The Role of Endothelins, IL-18, and NGAL in Kidney Hypothermic Machine Perfusion.

Authors:  Karol Tejchman; Adam Nowacki; Katarzyna Kotfis; Edyta Skwirczynska; Maciej Kotowski; Labib Zair; Marek Ostrowski; Jerzy Sienko
Journal:  Biomedicines       Date:  2021-04-13

Review 6.  Shifting Paradigms for Suppressing Fibrosis in Kidney Transplants: Supplementing Perfusion Solutions With Anti-fibrotic Drugs.

Authors:  L Leonie van Leeuwen; Henri G D Leuvenink; Peter Olinga; Mitchel J R Ruigrok
Journal:  Front Med (Lausanne)       Date:  2022-01-10

Review 7.  Ischemia-Reperfusion Injury Reduces Long Term Renal Graft Survival: Mechanism and Beyond.

Authors:  Hailin Zhao; Azeem Alam; Aurelie Pac Soo; Andrew J T George; Daqing Ma
Journal:  EBioMedicine       Date:  2018-02-02       Impact factor: 8.143

Review 8.  Heme-Oxygenase and Kidney Transplantation: A Potential for Target Therapy?

Authors:  Daniela Corona; Burcin Ekser; Rossella Gioco; Massimo Caruso; Chiara Schipa; Pierfrancesco Veroux; Alessia Giaquinta; Antonio Granata; Massimiliano Veroux
Journal:  Biomolecules       Date:  2020-05-30

Review 9.  Machine Perfusion of Extended Criteria Donor Organs: Immunological Aspects.

Authors:  Mindaugas Kvietkauskas; Bettina Leber; Kestutis Strupas; Philipp Stiegler; Peter Schemmer
Journal:  Front Immunol       Date:  2020-02-27       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.